According to anonymously-sourced whispers, LinkDoc, a provider of cancer-focused health care services using big data and artificial intelligence, had planned to sell 10.8MM shares priced between $17.50 and $19.50 each. Including the $4.4 billion raised by Didi, a total of 36 Chinese companies have sold shares in New York this year, raising a total of $12.6 billion, according to Dealogic. #SOURCES CHINABASED KEEP LINKDOC US IPOTIMES FULL#.(Bloomberg) - LinkDoc Technology Ltd., a Chinese medical data company, is seeking to raise money in a private fundraising, according to people familiar with the matter, after suspending plans for a July U.S. The firm, which is backed by Alibaba Health Information Technology Ltd., is considering raising between $200 million and $300 million, said one of the people, who asked not to be identified discussing private information.
CHINABASED KEEP LINKDOC US SOFTWARE
China-based government hackers have exploited a bug in Microsofts email server software to target U.S.
The fundraising comes as the firm is weighing a Hong Kong initial public offering, the people said. #Chinabased keep linkdoc us ipotimes software# Deliberations are ongoing and no decision has been reached, they said, adding the plan and details of the pre-IPO round and the Hong Kong IPO could still change. A representative for LinkDoc did not immediately respond to requests for comment. LinkDoc was slated to raise as much as $211 million from the U.S. All that said, let’s return first to LinkDoc, including a review of the bumpy road that brings us to the present, before looking at some of the other listings also in limbo. It pulled its listing plan at the last moment blaming market volatility, Bloomberg News reported in July, with the firm becoming the first known Chinese aspirant to halt its U.S. LinkDoc was one of a steady stream of money-losing but fast-growing tech companies to file for US listings, seeking to raise around 200 million through its IPO. IPO plans following Beijing’s crackdown on overseas listings. China Tightens Rules on Foreign IPOs in New Blow to Tech Firms LinkDoc Technology Ltd., a Beijing-based healthcare technology company, on Monday pulled plans for an initial public offering on the Nasdaq to raise up to 243 million.īeijing-based LinkDoc could revisit its listing plans when market conditions improve.Ĭhina is moving to plug regulatory gaps with new rules requiring nearly all companies seeking to list abroad to undergo a cybersecurity review.Shanghai Suspends Key Approval on Route to Offshore Listingsįounded in 2014, LinkDoc provides cancer focused health-care services built on big data and artificial intelligence, its website shows.Its investors, besides Alibaba Health, include MBK Partners, New Enterprise Associates and Temasek Holdings Pte., according to the preliminary filing in the U.S. and China have cast doubt on the plans of a slew of companies seeking to raise capital in New York from share sales.
J&T Express, an Indonesian courier company with significant operations in China, is weighing moving its planned U.S.
IPO to Hong Kong, Bloomberg News reported last month. Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States due to Beijings clampdown on overseas listings by domestic firms, according to three sources with direct knowledge of the matter. On-demand logistics and delivery firm Lalamove has also contemplated a similar move. #Chinabased keep linkdoc us ipotimes software#.
0 kommentar(er)
